tiprankstipranks
Global Blood Therapeutics (GBT)
NASDAQ:GBT

Global Blood Therapeutics (GBT) Ownership - Who Owns Global Blood Therapeutics?

0 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 29, 2022
Habibizad Nazila
Evp, Operations
Bought$570391
Sep 29, 2022Bought$387909
Sep 29, 2022
Ted Love
President & Ceo,director
Bought$299972
Sep 29, 2022
Choi Jung
Officer Title: Chief Business And Strategy Officer
Bought$699994

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2022Bought$594270
Jun 30, 2022Bought$1874282
Jun 30, 2022Bought$25747258
Jun 30, 2022Sold$30461002

Top Shareholders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top Mutual Fund Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Global Blood Therapeutics (GBT)?
Currently, no data Available
What percentage of Global Blood Therapeutics (GBT) stock is held by institutional investors?
Currently, no data Available
What percentage of Global Blood Therapeutics (GBT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Global Blood Therapeutics (GBT)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
    What's Included in PREMIUM?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis